Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL): a critical review-Reference-Cited by-同舟云学术

Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL): a critical review

Published:2018-05 Issue:5 Volume:29 Page:1120-1129
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Iacoboni G.,Zucca E.,Ghielmini M.,Stathis A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/5/1120/24831882/mdy113.pdf

Reference87 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60);Pfreundschuh;Lancet Oncol,2008

3. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group;Pfreundschuh;Lancet Oncol,2006

4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

5. Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: cALGB/Alliance 50303;Wilson;Blood,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma;Human Vaccines & Immunotherapeutics;2024-02

2. TNFAIP3 Overexpression Inhibits Diffuse Large B-Cell Lymphoma Progression by Promoting Autophagy through TLR4/MyD88/NF-κB Signaling Pathway;Discovery Medicine;2024

3. Hypoxia modulation vs. chemotherapy and tumor shrinkage on early response assessment in diffuse large B-cell lymphoma;Archive of Oncology;2024

4. Trial watch: chemotherapy-induced immunogenic cell death in oncology;OncoImmunology;2023-06-03

5. CLINICAL EFFICACY OF RITUXIMAB COMBINED WITH CHOP REGIMEN SEQUENTIAL OR NON-SEQUENTIAL LOCAL RADIOTHERAPY IN PATIENTS WITH STAGE III-IV DIFFUSE LARGE B-CELL LYMPHOMA;ACTA MEDICA MEDITERR;2023